Last updated: 2026-09-08 07:52:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Lyra Therapeutics, Inc. (LYRA) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0,00, with a market capitalization of -- and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0,00 to $8,75. This page covers its latest market performance, valuation, price trends and company information.
-- | |
-- | |
$1 100,00 | |
$0,00 | |
$0,68 | |
-- | |
-- | |
-- | |
$8,75 | |
$0,00 | |
-- | |
-- |
Lyra Therapeutics, Inc. (LYRA) last closed at $0,68 as of --, unchanged from the previous close of $0,68.
During the latest regular trading session, LYRA traded between $0,00 and $1 100,00, with a volume of 0,00 shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Lyra Therapeutics, Inc. (LYRA) moved from $0,20 to $0,00, representing a decline of 100,00% ($0,20).
The stock traded between $0,01 and $0,25 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 717,14 shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 0,0%
LYRA is currently trading at $0,00, placing it 0,0% of the way from its 52-week low of $0,00 to its 52-week high of $8,75. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
LYRA THERAPEUTICS INC
| Exchange | NASDAQ |
Eligible investors can buy real shares of Lyra Therapeutics, Inc. (LYRA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.